In addition to the new vaccine-specific product CPT codes, the CPT Editorial Panel has approved provisional CPT codes for booster doses of COVID-19 vaccines created by Moderna and Pfizer. While the Pfizer booster is likely to remain the same dose as the existing formulation, the Moderna booste...
Janssen’s COVID-19 vaccine is the fourth vaccine candidate to get its own CPT code from AMA, following the candidates fromPfizer,Moderna, andAstraZeneca. These unique CPT codes are created to clinically distinguish each vaccine and immunization administration for better tracking, reporting, and ana...
https://www.nih.gov/news-events/news-releases/promising-interim-results-clinical-trial-nih-moderna-covid-19-vaccine 32. Polack FP, Thomas SJ, Kitchin N, et al; C4591001 Clinical Trial Group. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. ...
Moderna’s mRNA-1273 vaccine is one of the most important vaccines which uses a synthetic lipid nanoparticle to carry mRNA templates. It translates the prefusion stabilized full-length spike protein of the SARS-CoV-2. Another one is BNT162b2 developed by BioNTech and Pfizer. It is a lipid ...